“Multiple Frontiers for Innovative Post-Pandemic Psychiatry”
CME Conference Webinar
Friday, November 5, 2021; 3:15 pm – 6:30 pm
Saturday, November 6, 2021; 8:00 am – 5:15 pm
Jointly provided by the American Psychiatric Association and the Oklahoma Psychiatric Physicians Association.
Presented with the Donahue-Shadid Psychiatric Alumni Association and the Oklahoma Council of Child and Adolescent Psychiatry.
- OPPA Member — $150 (Members of the Oklahoma Psychiatric Physicians Association)
- Non-OPPA Member — $155 (Includes non-member psychiatrists, other physicians and other healthcare professionals)
- Other Healthcare Professionals — $75 (PA, NP, RN, PhD, MSW)
- Psychiatric Resident — No Charge (To register, please send your name, school affiliation, PGY year and preferred email address to email@example.com)
Beginning in March 2020, our world as practicing psychiatrists changed. This 2021 Annual CME program of the Oklahoma Psychiatric Physicians Association will offer a unique educational experience and serve as a harbinger of the future of mid- 21st Century psychiatry.
The COVID-19 pandemic changed medical school education and psychiatric residency training. New onset psychosis resulting from COVID infection and other longstanding psychiatric sequelae of COVID infection, including the multiple stressors of isolation and economic devastation has resulted in the exponential increase in the use and abuse of methamphetamine and marijuana. Telemedicine treatment interventions for psychiatrists are increasingly common as are emerging new treatments such as Integrative Functional Medicine and infusion treatments for patients with depression and postpartum depression who are resistant to traditional psychopharmacology. An update on the opioid epidemic, which has yet taken a worse turn in Oklahoma, will be provided. (Attending this program will meet the requirement of the Oklahoma Medical Board of Licensure and Supervision.)
Research and clinical presentations by residents in Oklahoma’s Residency training programs promote the good feeling that the psychiatric profession is well-prepared to meet future challenges.
- Consider the impact of the COVID-19 Pandemic on medical and psychiatric education, and the effect of patient care and outcomes.
- Analyze newer treatment modalities of Ketamine and Esketamine via Intravenous infusion and via nasal spray for treatment resistant depressions, and Infusion treatment for post-partum depression.
- Evaluate how psychiatric practitioners can contribute to prevention of unnecessary opiate overdose related deaths.
- Determine a strategy for long-term professional success of psychiatrists despite intrusion by mid-level mental health professionals.
This program was developed for Oklahoma psychiatric physicians to learn how to adapt to meet the new challenges of a post-pandemic health care environment.
Continuing Education Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Psychiatric Association (APA) and the Oklahoma Psychiatric Physicians Association (OPPA). The APA is accredited by the ACCME to provide continuing medical education for physicians.
The APA designates this live activity for a maximum of 11 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit™ or a certificate of participation may do so by completing the program including the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the completion date and hours earned.
Program Faculty and Planners
Achina Stein, D.O. presenting “Strategies for the Medication Intolerant or Resistant Patient: A Functional Medicine Approach.”
Dr. Stein graduate of the UMDNJ School of Osteopathic Medicine, has been in practice as a board-certified psychiatrist for 25 plus years. Initially on a psychoanalytic track, she became well trained in psychodynamic psychotherapy and CBT and does psychotherapy with people with underlying trauma issues, specifically mood and dissociative disorders. She has much experience using psychopharmacology working with the prison, community mental health center with the chronic and persistent mental illness, and geriatric inpatient populations. She understood the limitations of treatment with medication and continually searched for other modalities of treatment.
Dr. Stein is a Distinguished Fellow of the American Psychiatric Association and awarded the Exemplary Psychiatrist Award by NAMI-RI in 2008. She is a former Clinical Assistant Professor of Psychiatry and Human Behavior of the Warren Alpert Medical School of Brown University.
She is presently in private practice in RI at Functional Mind, LLC, and Owner of an online group mental health coaching program, What If It’s Not Depression? Bootcamp, LLC, a companion program to her book, to assist people from a distance to reach their mental health goals.
Usha Tandon, M.D. presenting “Cannabis Use Disorder.”
Dr. Tandon is a Psychiatrist in Hollis, New York. She graduated with honors in 1973, having more than 48 years of diverse experiences, especially in psychiatry and addiction medicine. Dr. Tandon affiliates with Elmhurst Hospital Center, cooperates with many other doctors and specialists in many medical groups including New York City Health and Hospitals Corporation, Long Island Consultation Center, Inc.
George Dawson, M.D. presenting “Telepsychiatry in a Post Pandemic World and Beyond.”
Dr. Dawson is currently semi-retired, writes the blog Real Psychiatry and consults with other physicians. He was previously a Staff Psychiatrist at the Hazelden Betty Ford Foundation and an Adjunct Professor at the Hazelden Betty Ford Graduate School of Addiction Studies for ten years. Prior to that he was an acute care psychiatrist at Regions Hospital for 22 years where he also ran a Geriatric Psychiatry and Memory Disorders Clinic. His clinical and research interests have been in acute care, geriatric psychiatry, neuropsychiatry, and addiction psychiatry. He has extensive teaching experience with medical students, psychiatry residents, and CME courses and lectures on the neurobiology, psychopharmacology, epidemiology, and the clinical aspects of psychiatry. Dr. Dawson completed his training in psychiatry at the University of Wisconsin where he was a research fellow. Scholarly interests include biological psychiatry, consciousness studies, and the medical, philosophical, and political aspects of psychiatry.
Christopher Czapla, M.D. presenting “Teaching Mental Health while Aiding Public Health: Psychiatric Education in the Pandemic.”
Dr. Czapla is an assistant professor at the University of Oklahoma Department of Psychiatry and Behavioral Sciences. He went to medical school at OU College of Medicine and remained with the University for psychiatry residency in the Department of Psychiatry and Behavioral Sciences where he served as chief resident during his last two years in training. He currently serves as Program Director for the Residency at OU and director of OU Medical Center’s Psychiatric Consult and Liaison Team. He was the Director of OU College of Medicine’s Psychiatry Student Clerkship during the COVID-19 Pandemic. His professional interests include psychiatric education and treatment of psychiatric illness in medically ill patients.
Shannon Thomas, D.O. and Tessa Manning, M.D. presenting “Psychiatric Complications of COVID-19.”
Dr. Thomas graduated from Oklahoma State medical school and went on to complete her residency in psychiatry at the University of Oklahoma in Tulsa. She has been practicing in the outpatient mental health clinic of the Oklahoma City Veterans’ Affairs Medical Center and has been a volunteer faculty member with the University of Oklahoma psychiatry residency program since 2013. (Reports no financial relationships with commercial interests.)
Dr. Manning is an Assistant Professor in the Department of Psychiatry at the University of Oklahoma School of Medicine and currently serves as Medical Director for Consultation-Liaison Psychiatry. She completed her medical degree and Psychiatry residency at UT Southwestern Medical School in Dallas. She has been inducted into the Alpha Omega Alpha Honor Medical Society. Dr Manning is board certified by the American Board of Psychiatry and Neurology and the American Board of Preventative Medicine in Addiction Medicine. Her areas of interest include the treatment of psychiatric disorders in the medically ill, assisting patients gain recovery from addiction, and improving resident and medical student education.
Marsi Thrash presenting “Federal and State Legislative Advocacy.”
Ms. Thrash is one of four field-based Regional Directors of Government Affairs with the American Psychiatric Association who assists District Branches with legislative, advocacy and regulatory issues. This also includes Medicare, Medicaid, grassroots, and media needs. She covers all the states in Area 5: OK, MS, FL, GA, AL, LA, TX, AR, KY, SC, NC, TN, WV, and VA. Marsi has nearly 20 years of government affairs experience in health care both at the state and federal level. Prior roles include serving as the Georgia Government Relations Director at the American Heart Association, CME business development, Medicaid contracting, and campaign management. From 2000 – 2008 Marsi was the Government Affairs Director for TAP Pharmaceuticals (now absorbed into Takeda and Abbott) and lobbied FL, GA, AL, NC, SC, MS, and TN. While there she was also responsible for Medicaid and Medicare policy as well as patient and physician advocacy. A native of Pittsburgh, she holds a bachelor’s degree in Journalism from La Roche College and worked in print and broadcast media for several years. She also earned a dual MBA from the University of Pittsburgh Katz Graduate School of Business in Marketing and Finance.
Melanie Barrett, M.D. presenting “Postpartum Depression: It’s About Time.”
Dr. Barrett earned her medical degree from the University of Oklahoma College of Medicine after receiving a bachelor’s degree in psychology from Texas A&M University in College Station, Texas. She served as a Chief Resident at the University of North Carolina Hospitals, Chapel Hill. Dr. Barrett is board certified by the American Board of Psychiatry & Neurology. She is an outpatient Psychiatrist in Edmond and specializes in treating female patients with peri and postpartum mood disorders. She has been providing treatment with Brexanolone since December 2019. Dr. Barrett is a founding board member of The International Society of Reproductive Psychiatry (ISRP) which was founded to increase awareness, collaboration, and education in the field of reproductive psychiatry and hormone-mediated mood disorders.
Rachel Dalthrop, M.D. presenting “Innovation in Psychiatry: Ketamine, Esketamine and Psychedelic Psychotherapy.”
Dr. Dalthrop is a psychiatrist practicing in Oklahoma. She is a former board member of the American Society of Ketamine Physicians and a national presenter on the use of ketamine and esketamine in the treatment of mental health disorders. To date she has provided just over 8000 ketamine infusions and 3000 esketamine intranasal treatments to patients struggling with depression. Passionate about innovation, she is an early adapter of new therapies and enjoys sharing her clinical experiences with others.
Jason Beaman, D.O. presenting “Opioid Epidemic.” This program qualifies for the required yearly opioid abuse and misuse training for prescribers.
Dr. Beaman is Chair of Psychiatry and Behavioral Sciences at the Oklahoma State University Center for Health Sciences, Tulsa. After graduation from medical school, Dr. Beaman completed two simultaneous residencies in Psychiatry and Family Medicine. He then completed a Fellowship in Forensic Psychiatry and is board certified in Family Medicine, Psychiatry, Forensic Psychiatry and Addiction Medicine.
Shree Vinekar, M.D., CME Course Director; Britta Ostermeyer, M.D.; Jason Beaman, D.O.; Phebe Tucker, M.D.; Heather Geis, M.D.; S. Jay Lensgraf, M.D.; Arthur Rousseau, M.D.; Jedidiah Perdue, M.D.; Sara Coffey, D.O. and Maggie Lynn Montgomery, Course Contact.